Tumor-Agnostic Therapies: It’s All About the Target Shifting Focus From Site of Tumor Origin to Genetic/molecular Profile

Tumor-Agnostic Therapies: It’s All About the Target Shifting Focus From Site of Tumor Origin to Genetic/molecular Profile is organized by Projects In Knowledge Inc. (PIK).

Release Date: Feb 17, 2023
Termination Date: Feb 16, 2024

Activity Goal:
The goal is to provide clinicians with a resource to help them understand the key principles of the role of biomarkers to improve and optimize patient outcomes.

Learning Objective(s):
• Identify patients with tumors that harbor actionable biomarkers and are likely to benefit from biomarker-linked therapies.
• Summarize recent clinical safety and efficacy findings for therapies that can be used in a tumor-agnostic manner.     

Additional details will be posted as soon as information is available.    

0.5 MOC | 0.5 IPCE | 0.5 AMA PRA Category 1 Credit™ | 0.1 CEU | 0.5 Contact Hours